BIO China Deal Perspectives: A Dramatic Impact On Industry’s R&D Pipelines

Chinese Drug Development Speed Is Enviable

 
• By Mandy Jackson
  
Investors and drug developers outside of China are trying to figure out how to fit Chinese assets into their pipelines (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from BIO

More from Conferences